CMRX · Chimerix Inc.
Acquired Company
Jazz acquired Chimerix on 4/21/2025 for $8.55 per share in cash, representing a total transaction value of approximately $935 million.
Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina.
2505 MERIDIAN PARKWAY, DURHAM, NC, UNITED STATES, 27713, Durham, NC, 27713, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
801.1M
52 Wk Range
$0.00 - $0.00
Previous Close
$8.54
Open
$8.54
Volume
N/A
Day Range
$8.54 - $8.54
Enterprise Value
N/A
Cash
31.05M
Avg Qtr Burn
-19.27M
Insider Ownership
1.73%
Institutional Own.
56.44%
Qtr Updated
Mar 31st 2025